HOME › DRUGS › ASENAPINE
ACTIVE SUBSTANCE / INN

ASENAPINE

Brand name(s): SECUADO, Sycrest
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA212268
Bipolar Disorder
ACTIVE SUBSTANCE
Asenapine
REGULATORS
FDA · EMA
SPONSORS / MAH
Organon N.V., HISAMITSU
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SECUADONDA212268HISAMITSUPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SycrestOrganon N.V.Authorised01/09/2010Bipolar Disorder

FULL INTELLIGENCE ON ASENAPINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →